Great Britain approves Lecanemab for Alzheimer’s disease

/Ralf, stock.adobe.com London The drug Lecanemab for the treatment of early Alzheimer’s disease has received approval for certain patient groups in Great Britain from the British Medicines and Healthcare products Regulatory Agency (MHRA). According to